2-METHYLALANYL-N-(1-((1R)-1-(4-FLUOROPHENYL)-1-METHYL-2-OXO-2-(1-PYRROLIDINYL)ETHYL)-1H-IMIDAZOL-4-YL)-5-PHENYL-D-NORVALINAMIDE
UNII WH4V3479DC
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-methylalanyl-n-(1-((1r)-1-(4-fluorophenyl)-1-methyl-2-oxo-2-(1-pyrrolidinyl)ethyl)-1h-imidazol-4-yl)-5-phenyl-d-norvalinamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WH4V3479DC.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1357392-23-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H39FN6O3 WIMUBYAUCCQWLQ-OOWIMERYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-methylalanyl-n-(1-((1r)-1-(4-fluorophenyl)-1-methyl-2-oxo-2-(1-pyrrolidinyl)ethyl)-1h-imidazol-4-yl)-5-phenyl-d-norvalinamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.